COVIFOR

TNI Bureau: 'Covifor', the generic version of Remdesivir, has been received the approval from the Drug Controller General of India (DCGI) for the treatment of COVID-19. Hyderabad-based Hetero Healthcare Ltd. will deliver the first set of…